Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China
Abstract
Authors
J Zhu M Ye J Fu B Wu Y Chu Y Zhao Y Zhang D Kuo B Su